Ecolab Q3 adjusted EPS $2.07 (+13% YoY), sales $4.2B (+4%), guides FY25 adjusted EPS $7.48-$7.58

ECOLAB INC.

2025-Q3 EPS reported $5.30 vs consensus $2.09 ▲ beat (+153.2%)

Adjusted diluted EPS $2.07, +13% YoY; reported EPS $2.05 (-21% due to prior year gain on surgical solutions sale).
Organic sales +3% led by value pricing acceleration; organic operating margin 18.7% (+110 bps).
Growth engines (Life Sciences, Pest, Global High-Tech, Ecolab Digital) grew double-digits; Institutional & Specialty organic sales +4%.
FY 2025 adjusted EPS guidance narrowed to $7.48-$7.58 (+12-14%); Q4 expected $2.02-$2.12 (+12-17%).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.